Trials / Conditions / HER2-mutant Non-Small Cell Lung Cancer
HER2-mutant Non-Small Cell Lung Cancer
4 registered clinical trials studyying HER2-mutant Non-Small Cell Lung Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer NCT05650879 | Enliven Therapeutics | Phase 1 |
| Active Not Recruiting | A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mu NCT05246514 | AstraZeneca | Phase 2 |
| Unknown | A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer Wit NCT05411276 | Beijing Chest Hospital | — |
| Completed | Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Can NCT01827267 | Puma Biotechnology, Inc. | Phase 2 |